The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation
Open accessAbstract
The cytoplasm seems to provide an environment that favors conversion of the prion protein (PrP) to a form with the physical characteristics of the PrP Sc conformation, which is associated with transmissible spongiform encephalopathies. However, it is not clear whether PrP would ever exist in the cytoplasm under normal circumstances. We report that PrP accumulates in the cytoplasm when proteasome activity is compromised. The accumulated PrP seems to have been subjected to the normal proteolytic cleavage events associated with N- and C-terminal processing in the endoplasmic reticulum, suggesting that it arrives in the cytoplasm through retrograde transport. In the cytoplasm, PrP forms aggregates, often in association with Hsc70. With prolonged incubation, these aggregates accumulate in an “aggresome”-like state, surrounding the centrosome. A mutant (D177N), which is associated with a heritable and transmissible form of the spongiform encephalopathies, is less efficiently trafficked to the surface than wild-type PrP and accumulates in the cytoplasm even without proteasome inhibition. These results demonstrate that PrP can accumulate in the cytoplasm and is likely to enter this compartment through normal protein quality-control pathways. Its potential to accumulate in the cytoplasm has implications for pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J., & Hill, A. F. (1996) · Nature · doi:10.1038/383685a0 · Cited by 1,735
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 920
A Transmembrane Form of the Prion Protein in Neurodegenerative Disease
Hegde, R. S., Mastrianni, J. A., Scott, M. R., DeFea, K. A., Tremblay, P., Torchia, M., DeArmond, S. J., Prusiner, S. B., & Lingappa, V. R. (1998) · Science · doi:10.1126/science.279.5352.827 · Cited by 729
NMR characterization of the full‐length recombinant murine prion protein, m PrP(23–231)
Riek, R., Hornemann, S., Wider, G., Glockshuber, R., & Wüthrich, K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00920-4 · Cited by 722
Donne, D. G., Viles, J. H., Groth, D., Mehlhorn, I., James, T. L., Cohen, F. E., Prusiner, S. B., Wright, P. E., & Dyson, H. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13452 · Cited by 674
Protein Glucosylation and Its Role in Protein Folding
Parodi, A. J. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.69 · Cited by 658
UBIQUITIN AND THE CONTROL OF PROTEIN FATE IN THE SECRETORY AND ENDOCYTIC PATHWAYS
Bonifacino, J. S., & Weissman, A. M. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.19 · Cited by 613
Characterization and Dynamics of Aggresome Formation by a Cytosolic Gfp-Chimera✪
García-Mata, R., Bebök, Z., Sorscher, E. J., & Sztul, E. S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.6.1239 · Cited by 595
ER Quality Control: The Cytoplasmic Connection
Kopito, R. R. (1997) · Cell · doi:10.1016/s0092-8674(00)81881-4 · Cited by 518
Dynamic Association of Proteasomal Machinery with the Centrosome
Christian Wigley, W., Fabunmi, R. P., Lee, M. G., Marino, C. R., Muallem, S., DeMartino, G. N., & Thomas, P. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.3.481 · Cited by 513
Retrograde protein translocation: ERADication of secretory proteins in health and disease
Plemper, R. K., & Wolf, D. H. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01420-6 · Cited by 372
Reversible Conversion of Monomeric Human Prion Protein Between Native and Fibrilogenic Conformations
Jackson, G. S., Hosszu, L. L. P., Power, A., Hill, A. F., Kenney, J., Saibil, H., Craven, C. J., Waltho, J. P., Clarke, A. R., & Collinge, J. (1999) · Science · doi:10.1126/science.283.5409.1935 · Cited by 364
Genetic influence on the structural variations of the abnormal prion protein
Parchi, P., Zou, W., Wang, W., Brown, P., Capellari, S., Ghetti, B., Kopp, N., Schulz-Schaeffer, W. J., Kretzschmar, H. A., Head, M. W., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10168 · Cited by 330
Swanson, J., Bushnell, A., & Silverstein, S. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.1921 · Cited by 273
Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein
Yedidia, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5383 · Cited by 245
PNG1, a Yeast Gene Encoding a Highly Conserved Peptide:N-Glycanase
Suzuki, T., Park, H., Hollingsworth, N. M., Sternglanz, R., & Lennarz, W. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.5.1039 · Cited by 226
Caughey, B., Kocisko, D. A., Raymond, G. J., & Lansbury, P. T. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90087-x · Cited by 196
An Amber Mutation of Prion Protein in Gerstmann-Sträussler Syndrome with Mutant PrP Plaques
Kitamoto, T., Iizuka, R., & Tateishi, J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1447 · Cited by 189
Jin, T., Gu, Y., Zanusso, G., Sy, M., Kumar, A., Cohen, M., Gambetti, P., & Singh, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005543200 · Cited by 172
Lehmann, S., & Harris, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21479 · Cited by 169
Prion protein and the transmissible spongiform encephalopathies
Caughey, B., & Chesebro, B. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(96)10054-4 · Cited by 167
Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein
Zanusso, G., Petersen, R. B., Jin, T., Jing, Y., Kanoush, R., Ferrari, S., Gambetti, P., & Singh, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23396 · Cited by 165
Stimson, E., Hope, J., Chong, A., & Burlingame, A. L. (1999) · Biochemistry · doi:10.1021/bi982330q · Cited by 158
Tagliavini, F., Prelli, F., Porro, M., Rossi, G., Giaccone, G., Farlow, M. R., Dlouhy, S. R., Ghetti, B. F., Bugiani, O., & Frangione, B. (1994) · Cell · doi:10.1016/0092-8674(94)90554-1 · Cited by 142
Mutant Prion Proteins Are Partially Retained in the Endoplasmic Reticulum
Ivanova, L., Barmada, S. J., Kummer, T. T., & Harris, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106928200 · Cited by 141
Stewart, R. S., Drisaldi, B., & Harris, D. A. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.4.881 · Cited by 125
De novo generation of a PrPSc-like conformation in living cells
Ma, J., & Lindquist, S. L. (1999) · Nature Cell Biology · doi:10.1038/14053 · Cited by 117
Self-citationIn VivoAutopolysialylation and Localization of the Polysialyltransferases PST and STX
Close, B. E., & Colley, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34586 · Cited by 109
Most Pathogenic Mutations Do Not Alter the Membrane Topology of the Prion Protein
Stewart, R. S., & Harris, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006763200 · Cited by 76
Immunohistochemical studies of the PrPCJD deposition in Creutzfeldt‐Jakob disease
Tanaka, S., Saito, M. M., Morimatsu, M., & Ohama, E. (2000) · Neuropathology · doi:10.1046/j.1440-1789.2000.00285.x · Cited by 18
Cited by
Physiology of the prion protein
Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008) · Physiological Reviews · doi:10.1152/physrev.00007.2007 · Cited by 617
Prions: Protein Aggregation and Infectious Diseases
Aguzzi, A., & Calella, A. M. (2009) · Physiological Reviews · doi:10.1152/physrev.00006.2009 · Cited by 504
Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol
Ma, J., Wollmann, R., & Lindquist, S. (2002) · Science · doi:10.1126/science.1073725 · Cited by 487
Self-citationStress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection
Zanata, S. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf325 · Cited by 445
Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective
Tanaka, M., Kim, Y. M., Lee, G., Junn, E., Iwatsubo, T., & Mouradian, M. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310994200 · Cited by 422
Metadata
- Authors
- Ma, J., & Lindquist, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-12-11
- Volume
- 98
- Issue
- 26
- Pages
- 14955-14960
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2077672823
- Cited by
- 294
- References
- 32
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.